MorphoSys AG (MOR)
17.50
+0.10
(+0.55%)
USD |
NASDAQ |
May 01, 16:00
17.50
0.00 (0.00%)
After-Hours: 19:37
MorphoSys Profit Margin (Quarterly): 81.70% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 81.70% |
| September 30, 2023 | -187.5% |
| June 30, 2023 | -139.1% |
| March 31, 2023 | -71.30% |
| December 31, 2022 | |
| September 30, 2022 | -128.4% |
| June 30, 2022 | -395.3% |
| March 31, 2022 | -295.8% |
| December 31, 2021 | -720.0% |
| September 30, 2021 | -273.8% |
| June 30, 2021 | 54.65% |
| March 31, 2021 | -88.17% |
| December 31, 2020 | -45.85% |
| September 30, 2020 | -297.1% |
| June 30, 2020 | -288.6% |
| March 31, 2020 | 77.82% |
| December 31, 2019 | -454.3% |
| September 30, 2019 | -193.7% |
| June 30, 2019 | -16.91% |
| March 31, 2019 | -167.3% |
| December 31, 2018 | -413.6% |
| September 30, 2018 | 54.91% |
| June 30, 2018 | -289.7% |
| March 31, 2018 | -696.3% |
| December 31, 2017 | -52.18% |
| Date | Value |
|---|---|
| September 30, 2017 | -159.6% |
| June 30, 2017 | -136.8% |
| March 31, 2017 | -127.0% |
| December 31, 2016 | -220.7% |
| September 30, 2016 | -102.8% |
| June 30, 2016 | -95.52% |
| March 31, 2016 | -59.59% |
| December 31, 2015 | -108.3% |
| September 30, 2015 | -73.34% |
| June 30, 2015 | -35.55% |
| March 31, 2015 | 58.02% |
| December 31, 2014 | -5.90% |
| September 30, 2014 | -15.68% |
| June 30, 2014 | -3.59% |
| March 31, 2014 | 6.87% |
| December 31, 2013 | -24.63% |
| September 30, 2013 | -13.71% |
| June 30, 2013 | 35.49% |
| March 31, 2013 | 46.43% |
| December 31, 2012 | 19.15% |
| September 30, 2012 | -2.25% |
| June 30, 2012 | -3.54% |
| March 31, 2012 | -4.50% |
| December 31, 2011 | |
| September 30, 2011 | -11.67% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-720.0%
Minimum
Dec 2021
81.70%
Maximum
Dec 2023
-187.9%
Average
-163.3%
Median
Profit Margin (Quarterly) Benchmarks
| Incyte Corp | 19.84% |
| Novartis AG | 22.18% |
| Immatics NV | -164.2% |
| Affimed NV | -4.89K% |
| InflaRx NV | -696.8K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -308.8% |
| Return on Assets | -8.64% |
| Return on Invested Capital | -36.33% |
| Gross Profit Margin (Quarterly) | 75.20% |
| Operating Margin (Quarterly) | -137.7% |
| Return on Net Operating Assets | -12.30% |